News Image

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

Provided By GlobeNewswire

Last update: Jun 5, 2024

Oak Ridge, TN, June 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer. As part of his new responsibilities, Dr. Jefferies will leverage his extensive expertise to advise Daxor on strategic clinical and medical affairs matters and to facilitate the collaboration between the Company and healthcare professionals. He will be a key advisor, offering insights to inform corporate development strategies and advance the organization's growth objectives.

Read more at globenewswire.com

DAXOR CORP

NASDAQ:DXR (10/21/2025, 8:10:00 PM)

13.54

+0.26 (+1.96%)



Find more stocks in the Stock Screener

Follow ChartMill for more